Stay updated on Troriluzole Long-term Safety in OCD Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.

Latest updates to the Troriluzole Long-term Safety in OCD Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record now indicates that recruitment is no longer ongoing, signaling termination of participant enrollment. A new page revision tag Revision: v3.6.0 was added to the history.SummaryDifference0.4%

- Check19 days agoChange DetectedThe study history now shows a new revision entry (v3.5.5) replacing the previous revision (v3.5.4), indicating a small metadata update to the page.SummaryDifference0.1%

- Check40 days agoChange DetectedThe Record History now shows a new latest revision, v3.5.4, replacing the previous v3.5.3, reflecting an update to the page.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, signaling a new version of the page.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry v3.5.2 was added and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check91 days agoChange DetectedA new revision entry v3.5.0 was added to the record history.SummaryDifference0.1%

Stay in the know with updates to Troriluzole Long-term Safety in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.